指南与共识颈动脉与弓上血管

血管外科学会颅外脑血管疾病管理临床实践指南

Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease.
指南 / 共识 · J Vasc Surg · 2021-06-19

该指南更新并扩展了2011版,聚焦五个关键领域:CEA与最佳药物治疗、CEA与经股动脉CAS、急性卒中后干预时机、无症状患者筛查、合并冠心病患者的干预顺序。推荐对症状性低风险手术患者狭窄50%-99%及无症状患者狭窄70%-99%首选CEA,无症状患者围术期卒中和死亡风险需<3%。

要点

  • 症状性低风险手术患者狭窄50%-99%及无症状患者狭窄70%-99%首选CEA。
  • 无症状患者CEA围术期卒中和死亡风险需<3%以确保获益。
  • 近期稳定卒中(mRS 0-2)症状性狭窄>50%患者神经稳定后48小时至14天内血运重建。

核心结论

  • CEA是症状性低风险手术患者狭窄50%-99%及无症状患者狭窄70%-99%的一线治疗。
  • 无症状患者CEA围术期卒中和死亡风险需<3%以确保获益。

研究设计与样本

  • 血管外科学会基于随机对照试验、系统评价等证据更新2011版指南,采用GRADE方法制定推荐。

主要发现

  • 自2011版指南后有多项研究和系统评价比较CEA与CAS,并重新强调药物治疗作用。
  • 近期稳定卒中(mRS 0-2)症状性狭窄>50%患者神经稳定后48小时至14天内血运重建。
  • 普通人群无脑血管症状或显著危险因素者不推荐筛查颈动脉狭窄。
  • 选定无症状高风险患者若适合并愿意考虑干预可建议筛查。
  • 需CEA和CABG的症状性狭窄50%-99%患者,建议CEA先于或同期CABG。

关键数值与推荐

  • 症状性低风险手术患者狭窄50%-99%推荐CEA作为一线治疗。
  • 无症状患者狭窄70%-99%推荐CEA作为一线治疗,围术期卒中和死亡风险需<3%。
  • 近期稳定卒中(mRS 0-2)症状性狭窄>50%患者神经稳定后48小时至14天内血运重建。
  • 普通人群无脑血管症状或显著危险因素者不推荐筛查颈动脉狭窄。
  • 需CEA和CABG的症状性狭窄50%-99%患者,建议CEA先于或同期CABG。

临床怎么用

  • 对符合指征的症状性低风险手术患者及无症状患者,首选CEA而非CAS或单纯药物治疗。
  • 无症状患者行CEA前需确保围术期卒中和死亡风险<3%。
  • 急性稳定卒中患者应在神经稳定后48小时至14天内完成血运重建。
  • 合并冠心病的症状性颈动脉狭窄患者,CEA可先于或同期CABG。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Management of carotid bifurcation stenosis in stroke prevention has been the subject of extensive investigations, including multiple randomized controlled trials. The proper treatment of patients with carotid bifurcation disease is of major interest to vascular surgeons and other vascular specialists. In 2011, the Society for Vascular Surgery published guidelines for the treatment of carotid artery disease. At the time, several randomized trials, comparing carotid endarterectomy (CEA) and carotid artery stenting (CAS), were reported. Since the 2011 guidelines, several studies and a few systematic reviews comparing CEA and CAS have been reported, and the role of medical management has been reemphasized. In the present publication, we have updated and expanded on the 2011 guidelines with specific emphasis on five areas: (1) is CEA recommended over maximal medical therapy for low-risk patients; (2) is CEA recommended over transfemoral CAS for low surgical risk patients with symptomatic carotid artery stenosis of >50%; (3) the timing of carotid intervention for patients presenting with acute stroke; (4) screening for carotid artery stenosis in asymptomatic patients; and (5) the optimal sequence of intervention for patients with combined carotid and coronary artery disease. A separate implementation document will address other important clinical issues in extracranial cerebrovascular disease. Recommendations are made using the GRADE (grades of recommendation assessment, development, and evaluation) approach, as was used for other Society for Vascular Surgery guidelines. The committee recommends CEA as the first-line treatment for symptomatic low-risk surgical patients with stenosis of 50% to 99% and asymptomatic patients with stenosis of 70% to 99%. The perioperative risk of stroke and death in asymptomatic patients must be <3% to ensure benefit for the patient. In patients with recent stable stroke (modified Rankin scale score, 0-2), carotid revascularization is considered appropriate for symptomatic patients with >50% stenosis and should be performed as soon as the patient is neurologically stable after 48 hours but definitely <14 days after symptom onset. In the general population, screening for clinically asymptomatic carotid artery stenosis in patients without cerebrovascular symptoms or significant risk factors for carotid artery disease is not recommended. In selected asymptomatic patients with an increased risk of carotid stenosis, we suggest screening for clinically asymptomatic carotid artery stenosis as long as the patients would potentially be fit for and willing to consider carotid intervention if significant stenosis is discovered. For patients with symptomatic carotid stenosis of 50% to 99%, who require both CEA and coronary artery bypass grafting, we suggest CEA before, or concomitant with, coronary artery bypass grafting to potentially reduce the risk of stroke and stroke/death. The sequencing of the intervention depends on the clinical presentation and institutional experience.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. AbuRahma AF, Avgerinos ED, Chang RW, et al. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg. 2021. PMID: 34153348. doi:10.1016/j.jvs.2021.04.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。